|
About the study interpretation category
|
|
0
|
3786
|
July 21, 2018
|
|
RCT & Synthetic Data Generating Processes
|
|
0
|
81
|
September 13, 2026
|
|
Problems with NNT
|
|
37
|
40314
|
August 10, 2025
|
|
Non Inferiority vs Non significant
|
|
17
|
1771
|
December 19, 2024
|
|
Immortal-time-bias vs. selection bias
|
|
2
|
1876
|
April 7, 2024
|
|
Language for communicating frequentist results about treatment effects
|
|
200
|
126490
|
January 9, 2024
|
|
Article: JAMA meta-analysis of Placebo response and cannabis based therapies for pain
|
|
2
|
1501
|
December 3, 2022
|
|
Language regarding confidence in "negative" results
|
|
0
|
981
|
October 5, 2022
|
|
Should adverse effects be adjusted for multiple comparisons?
|
|
4
|
3795
|
May 24, 2022
|
|
Understanding "BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting]"
|
|
0
|
2053
|
January 18, 2022
|
|
Delphi Method Consensus
|
|
0
|
2382
|
December 9, 2021
|
|
Interpretation of the REGEN-COV trial
|
|
22
|
11504
|
November 1, 2021
|
|
Mathematical behavior of the primary endpoint
|
|
13
|
10225
|
March 2, 2021
|
|
Making sense of significant interaction with null main effect in RCT
|
|
3
|
11762
|
December 24, 2020
|
|
What are credible priors and what are skeptical priors?
|
|
62
|
35519
|
June 9, 2020
|
|
Lower limit of the confidence interval for measuring the magnitude of clinical benefit
|
|
8
|
4872
|
April 17, 2020
|
|
Very small effect size wih significant p-value
|
|
9
|
10126
|
April 5, 2020
|
|
What to interpret when observed effect size is smaller but statistically significant than expected effect size
|
|
18
|
21714
|
January 29, 2020
|
|
Prophetic variable in survival analysis - or not?
|
|
3
|
5301
|
January 3, 2020
|
|
Drawing inferences from frequentist point estimates with wide confidence intervals
|
|
2
|
3467
|
December 10, 2019
|
|
Comparing Beta coefficients
|
|
4
|
6801
|
October 11, 2019
|
|
Fragility Index
|
|
31
|
14763
|
August 24, 2019
|
|
Updates to NEJM Statistical Guidelines for Authors
|
|
20
|
19385
|
August 11, 2019
|
|
Interpreting the results of two non-inferiority trials
|
|
14
|
10314
|
July 31, 2019
|
|
GRADE guidelines and effect estimate & CIs
|
|
19
|
12465
|
July 10, 2019
|
|
Uncovering Waste in U.S. Healthcare
|
|
0
|
4274
|
June 14, 2019
|
|
CREOLE Trial: Interpretation of results doesn't line up with statistical plan?
|
|
7
|
5668
|
March 30, 2019
|
|
Most reasonably hypothesised effects cannot be exactly zero?
|
|
13
|
10646
|
March 29, 2019
|
|
Treatment effect heterogeneity: or is it?
|
|
12
|
8604
|
March 28, 2019
|
|
What does it mean when a test/predictor is 'predictive on the aggregate level but not on the individual level'
|
|
3
|
4244
|
March 6, 2019
|